<?xml version="1.0" encoding="UTF-8"?>
<p>There is a higher chance of developing surgical site infections in liver transplant recipient compared to other solid organ transplants. Treatment with trimethoprim sulfamethoxazole is generally used after liver transplantation for 3–12 months to reduce the risk of Pneumocystis but also to prevent infections with Listeria, Nocardia, Toxoplasma, and many other common infections [
 <xref ref-type="bibr" rid="CR181">181</xref>–
 <xref ref-type="bibr" rid="CR183">183</xref>]. The dose is a single-strength tablet taken daily or double-strength tablets taken thrice a week. The most common adverse effect is allergy and myelosuppression. It is also important to note that higher doses may increase the nephrotoxicity associated with cyclosporin or tacrolimus.
</p>
